[Molecular forms of prostate-specific antigen and their clinical significance].
PSA is a proteolytic enzyme produced in the prostatic epithelium and secreted into the seminal fluid. PSA can also be a constituent of the serum even under apparently normal conditions. In many cases of prostate cancer (PCa), increased serum concentrations are found. Elevated serum levels, however, are also observed in benign prostatic hypertrophy (BPH), thus limiting the specificity of serum PSA as a marker for prostate cancer. Recently, subfractions of PSA ("free PSA"; PSA-antichymotrypsin complex) were analyzed in order to gain a higher specificity of PSA as a tumor marker. The present paper describes biochemical features and clinical significance of the various PSA subfractions, pointing out an improved discrimination of PCa and BPH by evaluating the ratio "free PSA": total PSA.
Hilz
H
H
Institut für Physiologie Chemie, Universitätsklinik Eppendorf, Hamburg.
D014408:Biomarkers, Tumor / Q000097:blood* / Q000737:chemistry; D006801:Humans; D007527:Isoenzymes / Q000097:blood* / Q000737:chemistry; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood* / Q000737:chemistry; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000201:enzymology; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000201:enzymology; D012016:Reference Values; D013329:Structure-Activity Relationship
D014408:Biomarkers, Tumor; D007527:Isoenzymes; D017430:Prostate-Specific Antigen